Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, gives an overview of the current CAR-T climate in the field of multiple myeloma. Dr Raje highlights the results of the KarMMa study (NCT03361748), CARTITUDE-1 (NCT03548207), and EVOLVE (NCT03430011), all evaluating different BCMA-targeting CAR T-cell therapies that show activity in multiple myeloma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).